Search for: "Takeda Pharmaceuticals" Results 61 - 80 of 451
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Apr 2017, 5:45 pm by Lawrence B. Ebert
Back on 10 Feb. 17, MM commented on PatentlyO:Just fyi: another small batch of Rule 36 judgments was handed down today.On April 10, note the following under Rule 36:IN RE: MODERN WOODMEN OF AMERICA [RULE 36 JUDGMENT]TAKEDA PHARMACEUTICAL COMPANY v. [read post]
21 Mar 2017, 8:00 am by Robert Kreisman
Related blog posts: State Supreme Court Reverses for Family of Patient Who Died After Complications from Da Vinci Robotic Surgical System $9 Billion Actos Damage Award Against Takeda and Lilly is Upheld U.S. [read post]
29 Nov 2016, 2:30 am
  Italy has been particularly active in pursuing pharmaceutical companies over alleged anticompetitive behaviour. [read post]
26 Aug 2016, 7:25 am by Lawrence B. Ebert
One potential EpiPen competitor, Teva Pharmaceuticals, failed to obtain regulatory approval, delaying their entry into the market Another competitor, Sanofi, recalled its competing epinephrine delivery device because it may be delivering in incorrect dosage. [read post]
11 Aug 2016, 9:28 pm by Patent Docs
Takeda Pharmaceutical Co. [read post]
5 Aug 2016, 2:10 pm by Tom Lamb
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention   (Posted by Tom Lamb at DrugInjuryWatch.com)   This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors… [read post]
3 May 2016, 9:00 pm by Dennis Crouch
Guest Post By: Paul Dietze and Mini Kapoor, Haynes and Boone, LLP[1]  On March 18, 2016, the Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
29 Apr 2016, 10:04 am by Law Offices of Jeffrey S. Glassman
Takeda Pharmaceuticals, the makers of Actos, on the other hand, disagree with the link between their popular diabetes medication and bladder cancer and cite their own study data, which does not show such a causal link. [read post]
15 Apr 2016, 8:26 am by Tom Lamb
These medications are available by prescription and over-the-counter (OTC) from various pharmaceutical companies, for example: PRILOSEC (omeprazole magnesium) | prescription drug | AstraZeneca LPPRILOSEC OTC (omeprazole magnesium) | over-the-counter | Procter & Gamble Manufacturing Co.PREVACID (lansoprazole) | prescription drug | Takeda Pharmaceuticals America, Inc.PREVACID 24 HR (lansoprazole) | over-the-counter | Novartis Consumer Health, Inc.NEXIUM (esomeprazole… [read post]
8 Apr 2016, 11:05 am by Tom Lamb
Set Of Newer Diabetes Medications Containing Saxagliptin And Alogliptin Also Being Investigated By FDA For Increased Risk Of Renal Failure   (Posted by Tom Lamb at DrugInjuryWatch.com)   On April 5, 2016 the FDA took regulatory action by mandating that the pharmaceutical companies AstraZeneca and Takeda make label changes for some of their still relatively new diabetes drugs. [read post]
23 Nov 2015, 8:00 am by Robert Kreisman
Related blog posts: Takeda Pharmaceutical Agrees to $2.4 Billion Settlement Resolving Thousands of Bladder Cancer Cases Meningitis Outbreak Beginning to Draw Illinois Lawsuits Dietary Supplement DMAA Draws Health Warning       [read post]
20 Nov 2015, 7:56 am by Matthew L.M. Fletcher
Here: Takeda Opening Brief Connelly Answer Brief Takeda Reply Brief Lower court materials here. [read post]
14 Oct 2015, 9:35 am by Dr. Shezad Malik
Takeda Pharmaceuticals has decided to wrap up the remaining Actos linked bladder cancer lawsuits. [read post]